Tuoxin Pharmaceutical Group Co.,Ltd.

¥21.08As of Sun 8 Nov 2026, 12:00 UTC
SZSE:301089Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR (4.97%)
Div yield —
ROE (5.42%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.30
PE TTM —
TSR TTM (34.51%)
Mkt cap ¥2.668B
ROIC (6.57%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥22
2.05%
11.30%
Hold 1|8|8|7|2
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.29
0.30
0.33
0.31
23.81%
25.53%
33.33%
13.33%
Revenue¥M
241.9
240.8
254.8
252.3
18.32%
11.55%
12.16%
6.87%
Peers (US$399.9M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.269
0.106
0.106
EBIT/Intx
0.111
0.227
0.220
Own earn%
(83.33)
19.46
26.25
Sh yield%
24.23
44.31
46.64
Owners
Insiders/Inst%
13.41
64.51
Short interest%
3.58
SBC / revenue%
5.32
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
25–28
$1 testx
—
Incr. ROIC%
5